Original Research

Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo

Tan S, Wang G

Drug Design, Development and Therapy 2017, 11:3519-3529

Published Date: 8 December 2017